The study examined the effects of standardized Withania somnifera (ashwagandha) extract in women with polyendocrine metabolic ovarian syndrome. The research focused on the impact of this herb on endocrine and metabolic parameters, as well as psychometric indicators including depression symptoms and stress. The study included a group of women with polycystic ovarian syndrome (PCOS) and other metabolic disorders. Participants received either Withania somnifera or an active comparator as a dietary supplement. The research was conducted by the Medical University of Lodz and was successfully completed. The aim was to determine whether this natural substance could improve the health status of these patients.